Clinical Trials for Bladder Cancer

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

NCT ID: NCT04923178

This clinical trial is looking to learn more about urinary tract cancers, including those that are common, like bladder cancer, as well as rarer types that can affect the kidney, prostate, and test...

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

NCT ID: NCT06503146

This clinical trial is studying a new imaging method using a special substance called 18F-FAPI-74 to help detect certain types of cancer more effectively. The goal is to find out if this new tracer...

Evaluation for NCI Surgery Branch Clinical Research Protocols

NCT ID: NCT00001823

This clinical trial, led by the National Cancer Institute Surgery Branch (NCI-SB), is exploring new experimental treatments for various types of cancer, including synovial cell cancer, melanoma, co...

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT ID: NCT06257264

This clinical trial is studying a new treatment called BG-68501 for patients with advanced-stage tumors, including certain types of breast cancer, lung cancer, ovarian cancer, and others. The main ...

Blue Light Cystoscopy With Cysview® Registry

NCT ID: NCT02660645

The Blue Light Cystoscopy with Cysview® Registry is a clinical trial aimed at collecting more information about how doctors use a special technique called Blue Light Cystoscopy (BLCC) with a medica...

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT ID: NCT06465069

This clinical trial is studying a new drug called LY4052031 to see if it is safe and effective for patients with advanced or metastatic solid tumors, including types of bladder, breast, lung, and p...

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

NCT ID: NCT06973161

The ESPERANZA trial is studying the effectiveness of a medication called T-DXd in treating various types of solid tumors that express a protein known as HER2. This includes cancers like bladder, co...

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

NCT ID: NCT00026884

This clinical trial is focused on collecting blood and tissue samples from patients who have been diagnosed with or are suspected of having certain types of cancer, including kidney and bladder can...

TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation

NCT ID: NCT07038928

This clinical trial is a research study being done in several centers across Russia to learn more about bladder cancer. Specifically, it looks at how patients with different stages of bladder cance...

DESTINY-PANTUMOUR04

NCT ID: NCT07124000

This clinical trial, called DESTINY-PANTUMOUR04, is studying a medicine called T-DXd to see how well it works in people with certain advanced cancers that have a specific marker called HER2-positiv...

Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study

NCT ID: NCT07111364

This clinical trial is exploring a new way to use ultrasound images and artificial intelligence (AI) to better understand and stage bladder cancer. By combining different types of ultrasound scans,...

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT06172478

This clinical trial is studying a new treatment called HER3-DXd for patients with advanced solid tumors, which are cancers that have spread and cannot be treated with surgery or radiation. The tria...

Comparison of Apixaban Versus Enoxaparin

NCT ID: NCT06243510

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

NCT ID: NCT07129993

This clinical trial is studying a new treatment option for people with advanced or metastatic urothelial carcinoma, a type of bladder cancer that has spread or cannot be removed by surgery. The stu...

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

NCT ID: NCT07130578

This clinical trial is exploring a new way to help decide if patients with a certain type of early-stage bladder cancer, called high-risk non-muscle-invasive bladder cancer, really need a second su...

Cancer Loyalty Card Study 2 (CLOCS-2)

NCT ID: NCT06447064

The Cancer Loyalty Card Study 2 (CLOCS-2) is a research trial focused on improving early diagnosis of certain types of cancer, including pancreatic, colon, and ovarian cancers, among others. The st...

A Diagnostic for the Early Detection of Bladder Cancer

NCT ID: NCT05347342

This clinical trial is investigating a new way to detect bladder cancer early by testing a specific type of urine sample. The goal is to see how well this new test can identify people who are at hi...

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

NCT ID: NCT06814496

This clinical trial is investigating a new treatment approach for patients with certain types of cancer, including melanoma, thyroid cancer, and various other tumors. The main goal is to see if com...

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

NCT ID: NCT04442724

This clinical trial is investigating a new way to improve treatment for bladder cancer. Researchers want to see if placing tiny gold markers around the tumor can help doctors accurately find the tu...

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT ID: NCT06242470

This clinical trial is investigating a new treatment called MGC026 for adults with advanced solid tumors, which are types of cancer that have spread or cannot be removed through surgery. The study ...